Jun 07, 2023 / 02:00PM GMT
Maury Raycroft - Jefferies Group (Trades, Portfolio) - Analyst
Hi. My name is Maury Raycroft and then I'm of the biotech analysts at Jefferies. We're going to do a fireside chat today with ORIC. Got Jacob and Dominic with me. Thanks so much for joining us.
Maybe to start off if you guys want to provide a one-minute intro to ORIC.
Jacob Chacko - ORIC Pharmaceuticals, Inc. - President, CEO & Board Member
Sure. Happy to, Maury. Thanks for having us. So ORIC stands for Overcoming Resistance in Cancer, and that, in a nutshell, is the mission of the company. We are focused on small molecule drug development, and primarily in solid tumors, with one exception that we'll talk about, I'm sure, today.
There's a lot of expertise inside the company based on the team
Oric Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot